Skip to main content
. Author manuscript; available in PMC: 2015 Feb 5.
Published in final edited form as: Nat Commun. 2014 Aug 5;5:4579. doi: 10.1038/ncomms5579

Figure 3.

Figure 3

Changes in time to complete trails. Depiction of the change from baseline to post treatment in participants treated with escitalopram and participants treated with nCCR-GD on the Trail Making Test part B, a test of executive function measuring cognitive flexibility.